Nawah Scientific raises funding from CASF
- Egypt-based life science startup Nawah Scientific has raised an undisclosed sum from the Cairo Angels Syndicate Fund (CASF).
- Founded in 2015 by Omar Sakr, Nawah looks to empower scientific research and scientists in Egypt as well as the wider region. The company enables its business clients to conduct formulation development and stability studies, as well as all raw material and finished products quality control checks. Nawah is the first Mena-based company to issue certified reference materials (CRMs).
- This funding will go towards improving the startup's capabilities and scale growth.
Press release
The Cairo Angels Syndicate Fund (CASF), a micro venture capital fund that invests in early-stage startups in the Middle East and Africa, has announced its second investment backing the Life Sciences and Biotechnology startup Nawah Scientific in a dedicated round for CASF. Founded by Dr. Omar Sakr, Nawah Scientific is a core hub of advanced research equipment specialized in natural and medical sciences that offers its services online and on-demand. During 6 years of operations, Nawah has analyzed over 200K samples from 12 countries.
As one of the leading pharmaceutical formulation and analysis centers in Egypt, Nawah’s business model is revolutionizing the scientific research ecosystem allowing scientists to carry out world-class level research regardless of the equipment available in their labs. "We had the honor of having individual angel investors from the Cairo Angel Network as early investors. They came in when we needed them the most, provided us with capital, networking, support, and most importantly - with faith in what we are building. Now, Cairo Angels come with their Syndicate Fund to double down on the success we have built together, and I'm very excited about what is yet to come" stated Dr. Omar Sakr, Founder and CEO of Nawah.
This round of fundraising is geared towards helping the startup maintain its compelling growth and onboarding new projects. In light of this recent dedicated investment, given that The Cairo Angels network first invested in Nawah Scientific in 2020, CEO of the Cairo Angels Syndicate Fund Aly El Shalakany concluded, "Dr. Omar is a perfect example of what I call ‘brain regain’; a super talented and ambitious founder who, if truth be told, we would have lost in previous years to North America or Europe, were it not for the recent changes that have made it possible for entrepreneurs to succeed at home. Not only has Dr. Omar built an amazing, globally competitive and impactful business, but he has created a virtuous cycle for top scientists from Egypt to also succeed at home. We are immensely proud that we can continue to support Nawah Scientific in its mission.”